Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Polyrizon Ltd. - Ordinary Shares (NQ:PLRZ)

13.46 UNCHANGED

Streaming Delayed Price Updated: 3:59 PM EST, Mar 4, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1
Open	13.46
Bid (Size)	12.56 (100)
Ask (Size)	13.75 (100)
Prev. Close	13.46
Today's Range	13.46 - 13.46
52wk Range	2.880 - 2,235.00
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Polyrizon Announces Successful Study of its Naloxone Formulation Demonstrating Enhanced Nasal Deposition Profile Versus Commercial Reference Product

February 26, 2026

From Polyrizon Ltd.

Via GlobeNewswire

PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? ↗

February 10, 2026

Via Stocktwits

Performance

YTD	+5.6%	+5.6%
1 Month	-11.0%	-11.0%
3 Month	+89.8%	+89.8%
6 Month	+113.7%	+113.7%
1 Year	-98.8%	-98.8%

More News

Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator

February 10, 2026

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation

February 06, 2026

From Polyrizon Ltd.

Via GlobeNewswire

Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI

February 06, 2026

From Clearmind Medicine Inc.

Via GlobeNewswire

Polyrizon Intends to Acquire 51% Stake in Global Private Aviation Company

February 04, 2026

From Polyrizon Ltd.

Via GlobeNewswire

Top movers in Monday's session ↗

February 02, 2026

Via Chartmill

Monday's session: top gainers and losers ↗

February 02, 2026

Via Chartmill

Polyrizon Advances Regulatory Path with Initiation of Usability Study Program for NASARIX™ Allergy Blocker

January 22, 2026

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet

January 13, 2026

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™

January 08, 2026

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator

January 05, 2026

From Polyrizon Ltd.

Via GlobeNewswire

Wondering what's happening in today's pre-market session? ↗

January 05, 2026

Via Chartmill

Top stock movements in today's session. ↗

January 02, 2026

Via Chartmill

As Flu Surge Continues, Polyrizon's Nasal Spray Emerges as Potential Extra Shield Solution for Both Vaccinated and Unvaccinated

January 02, 2026

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon to Explore Revenue-Generating Real Asset Opportunities, Leveraging Strong Cash Position and Debt-Free Balance Sheet

December 29, 2025

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses

December 19, 2025

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program

December 11, 2025

From Polyrizon Ltd.

Via GlobeNewswire

There are notable gap-ups and gap-downs in today's session. ↗

December 08, 2025

Via Chartmill

Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray

December 08, 2025

From Polyrizon Ltd.

Via GlobeNewswire

These stocks are moving in today's after hours session ↗

December 05, 2025

Via Chartmill

Top movers analysis in the middle of the day on 2025-12-05: top gainers and losers in today's session. ↗

December 05, 2025

Via Chartmill

What's going on in today's pre-market session ↗

December 05, 2025

Via Chartmill

Keep an eye on the top gainers and losers in Thursday's session. ↗

December 04, 2025

Via Chartmill

Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion Naloxone Hydrogel Signals Stronger Real-World Opioid Overdose Reversal Potential

December 04, 2025

Via AB Newswire

Frequently Asked Questions

Is Polyrizon Ltd. - Ordinary Shares publicly traded?

Yes, Polyrizon Ltd. - Ordinary Shares is publicly traded.

What exchange does Polyrizon Ltd. - Ordinary Shares trade on?

Polyrizon Ltd. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Polyrizon Ltd. - Ordinary Shares?

The ticker symbol for Polyrizon Ltd. - Ordinary Shares is PLRZ on the Nasdaq Stock Market

What is the current price of Polyrizon Ltd. - Ordinary Shares?

The current price of Polyrizon Ltd. - Ordinary Shares is 13.46

When was Polyrizon Ltd. - Ordinary Shares last traded?

The last trade of Polyrizon Ltd. - Ordinary Shares was at 03/04/26 03:59 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.